https://www.zacks.com/stock/news/2213525/alvotech-alvo-up-on-bla-update-for-two-biosimilar-candidates?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2213525
Jan 22, 2024 - The FDA concludes the reinspection of Alvotech's (ALVO) facility in Iceland. The company believes that it may receive approval for biosimilar candidates, AVT02 and AVT04, in the United States. Stock rises.
zc:-1068902512350927246
0
https://seekingalpha.com/article/4663986-yields-up-to-9-2-percent-lifelong-passive-income-from-enbridge-and-mplx?source=feed
Jan 21, 2024 - Discover the top dividend stocks for generating passive income.
0
sa:5990344482315732435
0
https://seekingalpha.com/news/4056638-oil-up-for-the-week-down-for-the-day-as-china-concerns-offset-middle-east-turmoil?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Jan 19, 2024 - Crude oil prices were rangebound this week as concerns about China's economic growth offset Middle East tensions.
0
sa:-631788719573938496
0
https://www.cnbc.com/2024/01/19/beyond-yoga-names-athleta-gap-veteran-nancy-green-ceo.html
Jan 19, 2024 - Levi Strauss' Beyond Yoga has tapped former Athleta CEO and Gap veteran Nancy Green to be its next chief executive as the company looks to scale.
0
cnbc:-7384988588782760241
0
https://www.nrn.com/marketing/new-coca-cola-leader-lab-levels-next-generation-frontline-foodservice-leaders
Jan 19, 2024 - The free program provides Coca-Cola foodservice and on-premise partners an engaging approach to inspire an emerging, multicultural Gen Z leadership cohort in their career growth
0
nrn:-5690346551874494153
0
https://www.zacks.com/stock/news/2213012/dave-buster-s-play-up-36-in-three-months-more-upside-left?cid=CS-ZC-FT-analyst_blog|rank_focused-2213012
Jan 19, 2024 - Dave & Buster's (PLAY) focuses on introducing more entertainment options, enhancing guest engagement and implementing a digital guest platform to drive growth.
zc:-242042731993055080
0
https://www.zacks.com/stock/news/2212927/mesoblast-meso-up-on-rare-pediatric-disease-tag-for-heart-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2212927
Jan 19, 2024 - Mesoblast's (MESO) Revascor (rexlemestrocel-L) gets FDA's Rare Pediatric Disease designation for treating children with congenital heart disease. Shares rise in after-hours trading.
zc:6994723974281765028
0
https://www.zacks.com/stock/news/2212826/3m-mmm-gears-up-to-post-q4-earnings-is-a-beat-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2212826
Jan 19, 2024 - 3M's (MMM) fourth-quarter 2023 results are likely to have gained from strength across its automotive OEM and medical solutions businesses. However, weak commercial solutions and transportation safety markets might have hurt its results.
zc:-7049465733144145522
0
https://www.fool.com/investing/2024/01/19/why-amd-intel-and-qualcomm-stock-were-up-on-thursd/?source=iedfolrf0000001
Jan 19, 2024 - The semiconductor market is heading for a strong 2024.
0
fool:2007274323926944370
0
https://www.fool.com/retirement/2024/01/19/maxing-out-your-retirement-accounts-in-2024-heres/?source=iedfolrf0000001
Jan 19, 2024 - 401(k) and IRA contribution limits have gone up, so how big could your retirement account balance grow if you max out these accounts?
0
fool:-6852365455353481109
0